Global Cetuximab Market Growth 2022-2028
- LP 4798441
- 79 Pages
- January 2022
- Pharmaceuticals
The United States Cetuximab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cetuximab market, reaching US$ million by the year 2028. As for the Europe Cetuximab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cetuximab players cover Eli Lilly, Merck, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cetuximab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
100 mg/50 mL Injection
200 mg/100 mL Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Head and Neck Cancer
Metastatic Colorectal Cancer
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Eli Lilly
Merck
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cetuximab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cetuximab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cetuximab by Country/Region, 2017, 2022 & 2028
2.2 Cetuximab Segment by Type
2.2.1 100 mg/50 mL Injection
2.2.2 200 mg/100 mL Injection
2.3 Cetuximab Sales by Type
2.3.1 Global Cetuximab Sales Market Share by Type (2017-2022)
2.3.2 Global Cetuximab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cetuximab Sale Price by Type (2017-2022)
2.4 Cetuximab Segment by Application
2.4.1 Head and Neck Cancer
2.4.2 Metastatic Colorectal Cancer
2.5 Cetuximab Sales by Application
2.5.1 Global Cetuximab Sale Market Share by Application (2017-2022)
2.5.2 Global Cetuximab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cetuximab Sale Price by Application (2017-2022)
3 Global Cetuximab by Company
3.1 Global Cetuximab Breakdown Data by Company
3.1.1 Global Cetuximab Annual Sales by Company (2020-2022)
3.1.2 Global Cetuximab Sales Market Share by Company (2020-2022)
3.2 Global Cetuximab Annual Revenue by Company (2020-2022)
3.2.1 Global Cetuximab Revenue by Company (2020-2022)
3.2.2 Global Cetuximab Revenue Market Share by Company (2020-2022)
3.3 Global Cetuximab Sale Price by Company
3.4 Key Manufacturers Cetuximab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cetuximab Product Location Distribution
3.4.2 Players Cetuximab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cetuximab by Geographic Region
4.1 World Historic Cetuximab Market Size by Geographic Region (2017-2022)
4.1.1 Global Cetuximab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cetuximab Annual Revenue by Geographic Region
4.2 World Historic Cetuximab Market Size by Country/Region (2017-2022)
4.2.1 Global Cetuximab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cetuximab Annual Revenue by Country/Region
4.3 Americas Cetuximab Sales Growth
4.4 APAC Cetuximab Sales Growth
4.5 Europe Cetuximab Sales Growth
4.6 Middle East & Africa Cetuximab Sales Growth
5 Americas
5.1 Americas Cetuximab Sales by Country
5.1.1 Americas Cetuximab Sales by Country (2017-2022)
5.1.2 Americas Cetuximab Revenue by Country (2017-2022)
5.2 Americas Cetuximab Sales by Type
5.3 Americas Cetuximab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cetuximab Sales by Region
6.1.1 APAC Cetuximab Sales by Region (2017-2022)
6.1.2 APAC Cetuximab Revenue by Region (2017-2022)
6.2 APAC Cetuximab Sales by Type
6.3 APAC Cetuximab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cetuximab by Country
7.1.1 Europe Cetuximab Sales by Country (2017-2022)
7.1.2 Europe Cetuximab Revenue by Country (2017-2022)
7.2 Europe Cetuximab Sales by Type
7.3 Europe Cetuximab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cetuximab by Country
8.1.1 Middle East & Africa Cetuximab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cetuximab Revenue by Country (2017-2022)
8.2 Middle East & Africa Cetuximab Sales by Type
8.3 Middle East & Africa Cetuximab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cetuximab
10.3 Manufacturing Process Analysis of Cetuximab
10.4 Industry Chain Structure of Cetuximab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cetuximab Distributors
11.3 Cetuximab Customer
12 World Forecast Review for Cetuximab by Geographic Region
12.1 Global Cetuximab Market Size Forecast by Region
12.1.1 Global Cetuximab Forecast by Region (2023-2028)
12.1.2 Global Cetuximab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cetuximab Forecast by Type
12.7 Global Cetuximab Forecast by Application
13 Key Players Analysis
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Cetuximab Product Offered
13.1.3 Eli Lilly Cetuximab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
14 Research Findings and Conclusion
Table 1. Cetuximab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cetuximab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100 mg/50 mL Injection
Table 4. Major Players of 200 mg/100 mL Injection
Table 5. Global Cetuximab Sales by Type (2017-2022) & (K Units)
Table 6. Global Cetuximab Sales Market Share by Type (2017-2022)
Table 7. Global Cetuximab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Cetuximab Revenue Market Share by Type (2017-2022)
Table 9. Global Cetuximab Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Cetuximab Sales by Application (2017-2022) & (K Units)
Table 11. Global Cetuximab Sales Market Share by Application (2017-2022)
Table 12. Global Cetuximab Revenue by Application (2017-2022)
Table 13. Global Cetuximab Revenue Market Share by Application (2017-2022)
Table 14. Global Cetuximab Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Cetuximab Sales by Company (2020-2022) & (K Units)
Table 16. Global Cetuximab Sales Market Share by Company (2020-2022)
Table 17. Global Cetuximab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Cetuximab Revenue Market Share by Company (2020-2022)
Table 19. Global Cetuximab Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Cetuximab Producing Area Distribution and Sales Area
Table 21. Players Cetuximab Products Offered
Table 22. Cetuximab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cetuximab Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Cetuximab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Cetuximab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Cetuximab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Cetuximab Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Cetuximab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Cetuximab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Cetuximab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Cetuximab Sales by Country (2017-2022) & (K Units)
Table 34. Americas Cetuximab Sales Market Share by Country (2017-2022)
Table 35. Americas Cetuximab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Cetuximab Revenue Market Share by Country (2017-2022)
Table 37. Americas Cetuximab Sales by Type (2017-2022) & (K Units)
Table 38. Americas Cetuximab Sales Market Share by Type (2017-2022)
Table 39. Americas Cetuximab Sales by Application (2017-2022) & (K Units)
Table 40. Americas Cetuximab Sales Market Share by Application (2017-2022)
Table 41. APAC Cetuximab Sales by Region (2017-2022) & (K Units)
Table 42. APAC Cetuximab Sales Market Share by Region (2017-2022)
Table 43. APAC Cetuximab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Cetuximab Revenue Market Share by Region (2017-2022)
Table 45. APAC Cetuximab Sales by Type (2017-2022) & (K Units)
Table 46. APAC Cetuximab Sales Market Share by Type (2017-2022)
Table 47. APAC Cetuximab Sales by Application (2017-2022) & (K Units)
Table 48. APAC Cetuximab Sales Market Share by Application (2017-2022)
Table 49. Europe Cetuximab Sales by Country (2017-2022) & (K Units)
Table 50. Europe Cetuximab Sales Market Share by Country (2017-2022)
Table 51. Europe Cetuximab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Cetuximab Revenue Market Share by Country (2017-2022)
Table 53. Europe Cetuximab Sales by Type (2017-2022) & (K Units)
Table 54. Europe Cetuximab Sales Market Share by Type (2017-2022)
Table 55. Europe Cetuximab Sales by Application (2017-2022) & (K Units)
Table 56. Europe Cetuximab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Cetuximab Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Cetuximab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Cetuximab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Cetuximab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Cetuximab Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Cetuximab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Cetuximab Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Cetuximab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Cetuximab
Table 66. Key Market Challenges & Risks of Cetuximab
Table 67. Key Industry Trends of Cetuximab
Table 68. Cetuximab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Cetuximab Distributors List
Table 71. Cetuximab Customer List
Table 72. Global Cetuximab Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Cetuximab Sales Market Forecast by Region
Table 74. Global Cetuximab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Cetuximab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Cetuximab Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Cetuximab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Cetuximab Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Cetuximab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Cetuximab Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Cetuximab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Cetuximab Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Cetuximab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Cetuximab Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Cetuximab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Cetuximab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Cetuximab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Cetuximab Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Cetuximab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Cetuximab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Cetuximab Revenue Market Share Forecast by Application (2023-2028)
Table 92. Eli Lilly Basic Information, Cetuximab Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly Cetuximab Product Offered
Table 94. Eli Lilly Cetuximab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Eli Lilly Main Business
Table 96. Eli Lilly Latest Developments
Table 97. Merck Basic Information, Cetuximab Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Cetuximab Product Offered
Table 99. Merck Cetuximab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
List of Figures
Figure 1. Picture of Cetuximab
Figure 2. Cetuximab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cetuximab Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Cetuximab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cetuximab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100 mg/50 mL Injection
Figure 10. Product Picture of 200 mg/100 mL Injection
Figure 11. Global Cetuximab Sales Market Share by Type in 2021
Figure 12. Global Cetuximab Revenue Market Share by Type (2017-2022)
Figure 13. Cetuximab Consumed in Head and Neck Cancer
Figure 14. Global Cetuximab Market: Head and Neck Cancer (2017-2022) & (K Units)
Figure 15. Cetuximab Consumed in Metastatic Colorectal Cancer
Figure 16. Global Cetuximab Market: Metastatic Colorectal Cancer (2017-2022) & (K Units)
Figure 17. Global Cetuximab Sales Market Share by Application (2017-2022)
Figure 18. Global Cetuximab Revenue Market Share by Application in 2021
Figure 19. Cetuximab Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Cetuximab Revenue Market Share by Company in 2021
Figure 21. Global Cetuximab Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Cetuximab Revenue Market Share by Geographic Region in 2021
Figure 23. Global Cetuximab Sales Market Share by Region (2017-2022)
Figure 24. Global Cetuximab Revenue Market Share by Country/Region in 2021
Figure 25. Americas Cetuximab Sales 2017-2022 (K Units)
Figure 26. Americas Cetuximab Revenue 2017-2022 ($ Millions)
Figure 27. APAC Cetuximab Sales 2017-2022 (K Units)
Figure 28. APAC Cetuximab Revenue 2017-2022 ($ Millions)
Figure 29. Europe Cetuximab Sales 2017-2022 (K Units)
Figure 30. Europe Cetuximab Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Cetuximab Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Cetuximab Revenue 2017-2022 ($ Millions)
Figure 33. Americas Cetuximab Sales Market Share by Country in 2021
Figure 34. Americas Cetuximab Revenue Market Share by Country in 2021
Figure 35. United States Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Cetuximab Sales Market Share by Region in 2021
Figure 40. APAC Cetuximab Revenue Market Share by Regions in 2021
Figure 41. China Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Cetuximab Sales Market Share by Country in 2021
Figure 48. Europe Cetuximab Revenue Market Share by Country in 2021
Figure 49. Germany Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Cetuximab Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Cetuximab Revenue Market Share by Country in 2021
Figure 56. Egypt Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Cetuximab Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Cetuximab in 2021
Figure 62. Manufacturing Process Analysis of Cetuximab
Figure 63. Industry Chain Structure of Cetuximab
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
